Literature DB >> 10648847

Predicting the effectiveness of hydroxyurea in individual sickle cell anemia patients.

H Valafar1, F Valafar, A Darvill, P Albersheim, A Kutlar, K F Woods, J Hardin.   

Abstract

The study described in this paper was undertaken to develop the ability to predict the response of sickle-cell patients to hydroxyurea (HU) therapy. We analyzed the effect of HU on the values of 23 parameters of 83 patients. A Student's t-test was used to confirm (Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea, N Engl J Med 1990;322;1037-44) at the 0. 001 level that treatment with HU increases the proportion of fetal hemoglobin (HbF), and the average corpuscular volume (MCV) of the red blood cells. Correlation analysis failed to establish a statistically significant relationship between any of the 23 parameters and the HbF response. Linear regression analysis also failed to predict a patient's response to HU. On the other hand, artificial neural network (ANN) pattern-recognition analysis of the 23 parameters predicts, with 86.6% accuracy, those patients that respond positively to HU and those that do not. Furthermore, we have found that the values of only 10 of the 23 parameters (listed in the body of this paper) are sufficient to train ANNs to predict which patients will respond to HU.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648847     DOI: 10.1016/s0933-3657(99)00035-4

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  2 in total

1.  Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Authors:  Samir K Ballas; Robert L Bauserman; William F McCarthy; Oswaldo L Castro; Wally R Smith; Myron A Waclawiw
Journal:  J Pain Symptom Manage       Date:  2010-12       Impact factor: 3.612

2.  Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.

Authors:  Ramasamy Jagadeeswaran; Benjamin A Vazquez; Muthusamy Thiruppathi; Balaji B Ganesh; Vinzon Ibanez; Shuaiying Cui; James D Engel; Alan M Diamond; Robert E Molokie; Joseph DeSimone; Donald Lavelle; Angela Rivers
Journal:  Exp Hematol       Date:  2017-02-24       Impact factor: 3.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.